NCT05938725 · Interventional trial
KYSA-1: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus Nephritis
Overall registry status Terminated
Phase 1 · Phase 2
Conditions Lupus Nephritis, Lupus Nephritis - WHO Class IV, Lupus Nephritis - World Health Organization (WHO) Class III
Delaware Valley sites
- University of Pennsylvania · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory